Page 16 - PROPOSAL LATIP Zanamivir_Neat 2
P. 16
_drugs_origins_implications_barriers_solutions
Rizvi, S. A. A., & Saleh, A. M. (2018). Applications of nanoparticle systems in drug
delivery technology. Saudi Pharmaceutical Journal, 26(1), 64–70.
https://doi.org/10.1016/j.jsps.2017.10.012
Rohman, (2016), Validasi dan penjaminan mutu metode analisis kimia| OPAC
Perpustakaan Nasional RI. Perpusnas.go.id.
https://opac.perpusnas.go.id/DetailOpac.aspx?id=1134332
Sica, D. A. (2001). Combination Calcium Channel Blocker Therapy in the Treatment of
Hypertension. The Journal of Clinical Hypertension, 3(5), 322–327.
https://doi.org/10.1111/j.1524-6175.2001.00484.x
Sovan Lal Pal, Jana, U., Prabal Kumar Manna, & R. Manavalan. (2011, August).
Nanoparticle: An overview of preparation and characterization. ResearchGate;
unknown.
https://www.researchgate.net/publication/285680436_Nanoparticle_An_overview_o
f_preparation_and_characterization
Zanamivir: Uses, Interactions, Mechanism of Action | DrugBank Online. (2020).
Drugbank.com; DrugBank. https://go.drugbank.com/drugs/DB00558
Zeng, L., Liu, Y., Pan, J., & Liu, X. (2019). Formulation and evaluation of norcanthridin
nanoemulsions against the Plutella xylostella (Lepidotera: Plutellidae). BMC
Biotechnology, 19(1). https://doi.org/10.1186/s12896-019-0508-8
